Results 31 to 40 of about 9,601 (224)
Rheumatology & Autoimmunity, 2023 Introduction Statin‐associated immune‐mediated necrotizing myositis (IMNM) is a rare but distinct idiopathic inflammatory myopathy (IIM) that requires early recognition and intervention to prevent irreversible muscle damage. It is typically characterized
Nicole Daver, Sara Tonini
doaj +1 more source
Inclusion body myositis: Update on the diagnostic and therapeutic landscape
Frontiers in Neurology, 2022 Inclusion body myositis (IBM) is a progressive muscle disease affecting patients over the age of 40, with distinctive clinical and histopathological features. The typical clinical phenotype is characterized by prominent involvement of deep finger flexors
Elie Naddaf
doaj +1 more source
Making the Diagnosis of Myositis: Definition and Classification of Myositis
, 2020 Myositis is a heterogeneous group of autoimmune diseases encompassing a large spectrum of clinical manifestations including some patients presenting with no muscle involvement. Thus, the clinician must be aware that arthritis, certain cutaneous features,
Lundberg, IE, Leclair, V
core +1 more source
Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
Biomolecules, 2019 The sporadic form of inclusion body myositis (IBM) is the most common late-onset myopathy. Its complex pathogenesis includes degenerative, inflammatory and mitochondrial aspects.
Boel De Paepe
doaj +1 more source
Inclusion body myositis with granuloma formation in muscle tissue
, 2017 Inclusion body myositis is a form of inflammatory myopathy. We identified 4 cases of inclusion body myositis showing granuloma formation in muscle tissue and aimed to assess the features of this atypical form of inclusion body myositis.
Ishida, Chiho +6 more
core +2 more sources
Polymyositis and dermatomyositis: Disease spectrum and classification
Indian Journal of Dermatology, 2012 Muscle inflammation and weakness are the key features of idiopathic inflammatory myopathies (IIMs). In addition IIMs are frequently associated with cutaneous and pulmonary involvement. In clinical practice the three common inflammatory myopathies we come
Siba P Raychaudhuri, Anupam Mitra
doaj +1 more source
ContinuumThis article addresses the clinical presentation, diagnostic workup, and management of patients with inclusion body myositis (IBM). It also provides an overview of the clinical trial landscape and explores future directions in the pursuit of an effective treatment for the disease.Muscle biopsy remains the cornerstone of the diagnosis, and cytosolic ...
Warman-Chardon, Jodi +2 more
openaire +4 more sources
Cardiology Discovery. Previous studies have reported elevated cardiac troponin T (cTnT) in patients with inclusion body myositis due to skeletal myopathy. Although the trends of cTnT have been reported in some cases, the onset of elevation has barely been reported.
Zhiqing Fu, Xiujin Zhang, Hanjia Gao
doaj +1 more source
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
Frontiers in Immunology, 2019 Objective: Sporadic Inclusion Body Myositis (sIBM) is an inflammatory myopathy (IIM) without a specific diagnostic biomarker until autoantibodies to the cytosolic 5′-nucleotidase 1A (NT5c1A/Mup44) were reported.
Adam Amlani +11 more
doaj +1 more source
Differential Diagnoses of Inclusion Body Myositis [PDF]
, 2020 Inclusion body myositis is a slowly progressive myopathy, characteristically affecting quadriceps and long finger flexors. Atypical presentations do occur, however, and there is overlap with other myopathies, including inflammatory and hereditary ...
Bugiardini, E +6 more
core